Dilution for as far as you can see and the low volume means interest is dying up.
The most important factor going forward is liquidity. These two toxic lenders likely have banked more than a million dollars on the estimated 243,720,564 that have been eligible. At a price average of say $0.005 as share we are looking at $1,218,602 off a conversion price of .00017 a share. That took the patent press release which we all know now is useless due to the regulatory rules currently in place regarding securities trading. Now consider the analysis in my my post below for perspective on what needs to be done to move the roughly 454,279,436 shares becoming eligible.
Bubae Re: NorthPeak22 post# 4462 Monday, December 11, 2023 6:23:38 PM Post# 6659 of 6741 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173407134 . ..I concluded that roughly 243,720,564 of the 698,000,000 were eligible during this period of heavy volume since October 24th.... Now consider that I also estimate that by next week the balance of roughly 454,279,436 of that group will become eligible on a rolling basis over the next three months.
Take a look at the one month chart with a frequency of thirty minuets. See that cycle of sell off and recovery on heavy volume? With all than is now known and is becoming more widely understood, do you think this can even get a small portion of that activity going forward?
News 
Market Data 
Discover 
AI
